Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Regeneron Pharmaceuticals · NCT07594093

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
90
US sites recruiting
1
Study start
June 29, 2026
Record last updated
September 25, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study will test a study drug called REGN20934 to see how safe and well tolerated this drug is, as well as how the drug is processed in the body for participants with overweight or obesity.

The study is looking at

  • What side effects REGN20934 might cause
  • How much REGN20934 is in the blood at different times
  • If the body makes antibodies to REGN20934

Being studied: REGN20934; Placebo

Conditions: Overweight or Obesity

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Key Inclusion Criteria

  • Has a Body Mass Index (BMI) 25 to 35 kg/m\^2
  • Females must be of non-childbearing potential

Key Exclusion Criteria

  • A self-reported change of body weight >5 kg within approximately 90 days of visit 2
  • History of type 1 or type 2 diabetes
  • History of clinically significant cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, psychiatric, or neurological disease, as defined in the protocol

Note: Other protocol defined inclusion/exclusion criteria apply

Recruiting US locations

Study contacts (from the official record)

  • Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
All weight loss studies in California →
Safety and Drug Concentrations of REGN20934 in Adults With… (NCT07594093) | Bored Studies